Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 14,384 shares at $9.26 ($133K) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Seasonal sale ($133k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.26 | 7,192 | $67K | 50.0% |
| 2 | $9.26 | 7,192 | $67K | 50.0% |
| Total | $9.26 avg | 14,384 | $133K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |